- Atomoxetine use during a period of FDA actionsDongyi Tony Du
Office of Commissioner, US Food and Drug Administration FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
Med Care 50:987-92. 2012..At FDA's request, the manufacturer subsequently added a boxed warning to the drug's labeling on November 8, 2005...
- Despite 2007 law requiring FDA hotline to be included in print drug ads, reporting of adverse events by consumers still lowDongyi Du
Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA
Health Aff (Millwood) 31:1022-9. 2012..The study results suggest that additional measures, such as more publicity about the Adverse Event Reporting System or more consumer education, should be considered to promote patient reporting of adverse events...